UPDATE: Puma Biotech (PBYI) Sees Heavy Selling Pressure; SABCS Abstracts Released
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - November 14, 2016 10:55 AM EST)
Puma Biotech (NYSE: PBYI) is under heavy pressure. Shares down 17.7%
UPDATE: Downdside could be coming as SABCS abstracts were released. Link
There is also talk amongst traders about a PR Friday discussing a shareholder investigation. Shares last traded down 35% before being halted on a circuit breaker.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Puma Biotech (PBYI) Commences PB272-Focused MAP
- Western Digital (WDC) volatility flat into shares rallying on upbeat analyst day and raised guidance
- December volatility at 29 report and outlook
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!